Literature DB >> 29636642

Correction to: Knockdown of miR-155 protects microglia against LPS-induced inflammatory injury via targeting RACK1: a novel research for intracranial infection.

Haiyan Yin1,2, Shuwen Song3, Xudong Pan4.   

Abstract

[This corrects the article DOI: 10.1186/s12950-017-0162-7.].

Entities:  

Year:  2018        PMID: 29636642      PMCID: PMC5883406          DOI: 10.1186/s12950-018-0183-x

Source DB:  PubMed          Journal:  J Inflamm (Lond)        ISSN: 1476-9255            Impact factor:   4.981


Correction

Upon publication of the original article [1] it was highlighted by the authors that the first affiliation of author Haiyan Yin was incorrectly cited in duplicate as “Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, 272000, China”. This should instead read “Qingdao University, Qingdao, 266,071, China”. This error in the author details has since been formally noted in this correction article.
  1 in total

1.  Knockdown of miR-155 protects microglia against LPS-induced inflammatory injury via targeting RACK1: a novel research for intracranial infection.

Authors:  Haiyan Yin; Shuwen Song; Xudong Pan
Journal:  J Inflamm (Lond)       Date:  2017-08-09       Impact factor: 4.981

  1 in total
  1 in total

1.  MiR-155/GSK-3β mediates anti-inflammatory effect of Chikusetsusaponin IVa by inhibiting NF-κB signaling pathway in LPS-induced RAW264.7 cell.

Authors:  Yi Xin; Qin Yuan; Chaoqi Liu; Changcheng Zhang; Ding Yuan
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.